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P
ericardial effusions are present in a variety of pathologic conditions. The advent of echocardiography has provided an accurate noninvasive method for diagnosing the presence of such effusions. 1 However, the etiology of the effusion is often uncertain and cannot always be clearly defined on the basis of clinical assessment or even autopsy. 2 With few validated tests available, investigators have successfully made correct diagnoses on pericardial fluid analysis in 24 to 93% of cases in reported series. 1, 3 Rapid diagnosis and treatment are, however, crucial in reducing morbidity and mortality from pericardial disease. 4 In contrast to the relatively well-documented ability of tests on pleural fluids to identify the cause of pleural effusions, only one study 1 has reported the systematic evaluation and utility of various diagnostic tests when applied to pericardial fluids. The purpose of this study was to examine the diagnostic utility of several biochemical tests in pericardial fluids.
Materials and Methods
A prospective study was carried out from February 1995 to February 1998 at Tygerberg Hospital, South Africa; consecutive patients who presented to the echocardiography department with large pericardial effusions were included in the study. All patients gave written informed consent for participation in the study, which was approved by the Ethics Committee of the University of Stellenbosch. Each patient was subjected to a full clinical examination, chest radiography, ECG, echocardiography, HIV testing, and sputum Ziehl-Nielson (ZN) staining. A pericardial tap was performed under echocardiographic guidance through a pigtail catheter, and the fluid sent for examination of biochemistry, adenosine deaminase (ADA), microbiology (including ZN staining and culture for Mycobacterium tuberculosis), and hematology. The patient was followed up daily for signs of cardiac tamponade and/or recurrence of effusion.
A total of 110 pericardial effusions were collected during this 3-year period. The hospital records of all patients were reviewed, and a diagnosis was made according to predetermined criteria. Tuberculous pericarditis was diagnosed if one or more of the following criteria was met: (1) identification of the bacillus in pericardial fluid or biopsy specimen by stain and/or by culture, or by the presence of granulomas in pericardial biopsy tissue; (2) positive sputum ZN and/or culture findings in the presence of clinical and radiologic evidence of tuberculosis and in the absence of any other obvious cause associated with pericardial effusions; and (3) clinical and radiologic evidence of tuberculosis in the absence of any other obvious cause associated with pericardial effusions and associated with a positive response to antituberculous therapy. Infective effusions included: (1) pericardial effusions associated with acute febrile illness and responsiveness to antibiotic treatment or identification of the organism in the pericardial fluid; (2) septicemia, characterized by pericardial effusions and multisystem involvement in the presence of positive blood culture findings; and (3) other obvious infective conditions in the absence of any other cause associated with pericardial effusions. Neoplastic effusions were diagnosed when one of the following criteria was met: (1) the presence of cytologic and/or histologic evidence of a malignant pericardial effusion, or (2) histologic proof of a malignant tumor with exclusion of any other cause known to be associated with pericardial effusions. Other effusions were defined by effusions that were clearly caused by collagen vascular disease, congestive heart failure (CHF), uremia, renal failure, and various other rare but well-documented causes of pericardial effusions. Idiopathic effusions were defined as effusions that were not due to any demonstrable cause. A full diagnostic workup had been performed in these patients, and all test results were negative. Patients having multiple superimposed diseases or effusions of unknown origin (that is, all possible etiologic causes could not be excluded) were classified as "indeterminate origin."
The effusions were classified, according to the etiologic diagnosis, as being transudates or exudates. Only six effusions were included in the transudative group (two patients with CHF and four patients with renal failure). For this reason, 12 control patients were also included in this group for the purpose of this study. Control patients were evaluated by obtaining pericardial fluid during routine open-heart surgery (nine coronary artery bypass procedures and three aortic valve replacements) by open pericardial aspiration. None of these patients had diseases or were receiving medications known to cause pericardial effusions; in addition, none of these patients had experienced myocardial infarctions in the preceding 1 month.
The following parameters were estimated and calculated: (1) the criteria of Light et al 5 (these criteria, initially described in pleural fluids, were modified accordingly for pericardial fluids to include pericardial fluid/serum [Pc/S] protein ratio, Pc/S lactate dehydrogenase [LDH] ratio, and pericardial fluid LDH concentration); (2) total cholesterol; (3) Pc/S cholesterol ratio; (4) serumeffusion albumin gradient (SEAG); and (5) Pc/S bilirubin ratio.
The accuracy of each test in distinguishing between pericardial exudates and transudates was established. In addition, the utility of each biochemical parameter for identifying pericardial effusions was evaluated by calculating sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy. Interval (continuous) variables were expressed as mean (SD). Nonparametric data were expressed as median (range). Statistical analysis of continuous variables was performed using the Mann-Whitney U test. A p value Ͻ 0.05 was considered statistically significant.
Results
The results from 122 pericardial fluids were analyzed, including 110 due to large pericardial effusions and 12 from control patients. In 10 cases, the pericardial effusion was secondary to multiple (n ϭ 6) or unknown (n ϭ 4) causes; these effusions were excluded. The remaining 112 effusions included 94 exudative effusions and 18 transudative effusions. Exudative effusions included those diagnosed as tuberculous (n ϭ 64), malignant (n ϭ 12), infective (n ϭ 5), and "other" exudates (n ϭ 13), based on the degree of inflammation inherent in each disease process. 2, 6, 7 Transudates included those effusions due to renal failure (n ϭ 4), CHF (n ϭ 2), and normal control subjects (n ϭ 12). There were no significant differences in any biochemical parameters between transudates resulting from CHF or renal failure, and those collected from normal control patients.
Exudative effusions were then compared with transudates. While the RBC counts were similar, exudates had significantly higher fluid leukocyte counts than transudates (median, 2.97 ϫ 10 Table 1 .
The ability of each test to correctly classify fluid as exudate or transudate was evaluated using the cutoff points generally used for pleural fluids.
Exudate Criteria
According to the criteria of Light et al, 5 an exudate is defined as fulfilling one or more of the following: pleural fluid/serum (P/S) protein ratio Ͼ 0.5; pleural fluid LDH concentration Ͼ 200 U/L; and/or P/S LDH ratio Ͼ 0.6. These criteria were applied to pericardial fluids and estimated in 112 patients; 105 of the patients were correctly classified (diagnostic efficiency, 94%). The sensitivity and specificity for an exudate were calculated at 98% and 72%, respectively.
Two of the 94 patients having exudates were misclassified as transudates. These included one patient with an idiopathic pericardial effusion and one patient with systemic sclerosis. Of the transu-dates, 5 of 18 were misclassified. These included four patients with renal failure (two of which had albumin gradients that fell in the transudative range) and one patient with CHF (in this case, the albumin gradient was suggestive of a transudate). In all five of these cases, the patients were receiving concomitant diuretic therapy. The PPV and NPV for identifying exudates were calculated as 94% and 87%, respectively.
SEAG
Based on the work done by Roth et al, 8 SEAG Յ 12 g/L is used to identify pleural exudates; a pleural transudate is thus described as having a gradient Ͼ 12 g/L. The SEAG was established in 105 patients with pericardial effusions. By this method, 94 patients were correctly classified, yielding an efficiency of 90%.
Of the exudates, 78 of 87 were correctly classified, yielding a sensitivity for exudates of 90%. The specificity of the SEAG was calculated as 89%, based on the fact that 16 of 18 transudates were correctly classified. Both transudates that were misclassified by this method were due to renal failure; according to the criteria of Light et al 5 they were also classified as exudates.
The PPV and NPV for the identification of exudates were 98% and 64%, respectively. Various other cutoff levels for the SEAG were tested, but these did not increase the sensitivity or specificity of the test.
Effusion Cholesterol Concentration
Based on previous studies 9,10 done in pleural effusions, a cutoff point of 60 mg/dL (1.55 mmol/L) yields the best results. Pleural exudates are classified as having a cholesterol concentration Ն 60 mg/dL (that is, Ն 1.55 mmol/L), and transudates Ͻ 60 mg/dL (or Ͻ 1.55 mmol/L). Using this cutoff level, 60 of 103 effusions were correctly classified. This yielded an efficiency, sensitivity, and specificity (for exudates) of 73%, 71%, and 83%, respectively.
Of the 85 exudates, 60 were correctly classified, while 15 of the 18 transudates were correctly classified. The three transudates that were misclassified were all due to renal failure; only one transudate was correctly classified by the criteria of Light et al. 5 The PPV and NPV were 95% and 38%, respectively. Different cutoff levels for cholesterol concentration were applied. The best results were obtained using a cutoff level of 1.15 mmol/L. At this level, sensitivity, specificity, PPV, NPV, and efficiency were 88%, 56%, 90%, 50%, and 83%, respectively. Use of SEAGs did not affect our results.
Pc/S cholesterol ratios were also calculated at various cutoff points. Although Hamm et al 9 demonstrated that application of a P/S cholesterol ratio did not affect the sensitivity and specificity of this test, this was not the case in our pericardial population. A cutoff ratio of 0.25 yielded an accuracy, sensitivity, and specificity of 87%, 91%, and 67%, respectively; increasing the cutoff ratio to 0.3 yielded results of 88%, 91%, and 83%, respectively.
Pc/S Bilirubin Ratio
Meisel et al 11 described pleural exudates as having a P/S bilirubin ratio Ն 0.6. Pc/S bilirubin ratios were calculated in 101 patients with pericardial effusions in the present study. Best results were obtained using a cutoff level of 0.5. Of the 84 exudates, 76 were correctly classified, and 11 of 17 transudates were correctly classified. Efficiency, sensitivity, and specificity for the detection of pericardial exudates were 86%, 90%, and 65%, respectively. The PPV was 93%, and the NPV was 58%. 2 demonstrated that exudates and transudates are best discriminated by specific gravity Ͼ 1.015, fluid protein level Ͼ 30 g/L, Pc/S protein ratio Ͼ 0.5, fluid LDH value Ͼ 300 U/L, and Pc/S LDH ratio Ͼ 0.6. Another article 12 reporting three ill-defined cases with purported transudative pericardial fluid noted specific gravities of 1.018 to 1.022, protein levels of 44 to 50 g/L, and glucose levels of 70 to 90 mg/dL. A further case series noted that inflammatory pericardial fluid had a mean (SD) pH of 7.06 (0.07) compared with noninflammatory fluid, which had a mean Ϯ SD pH of 7.42 Ϯ 0.06. 13 From the current study, the criteria of Light et al 5 was the most sensitive diagnostic tool (98%) for identifying pericardial exudates. The corresponding specificity was 72%. The major disadvantage appears to be the misclassification of transudates as exudates, especially when the patient is receiving concurrent diuretic therapy. The occurrence of an exudative range of protein levels in patients with CHF receiving diuretic therapy was described in pleural effusions by Pillay 14 and Chakko et al. 15, 16 It is probable that a similar mechanism exists in the case of pericardial effusions.
The SEAG has been used successfully in pleural effusions 8 and ascites [17] [18] [19] to discriminate between exudates and transudates. Application of this concept to pericardial effusions resulted in a sensitivity and specificity of 90% and 89%, respectively, for the identification of pericardial exudates. The major advantage of this biochemical test was the reduction in the number of patients with transudates receiving concurrent diuretic therapy being misclassified as having exudates.
The use of effusion cholesterol levels, Pc/S cholesterol ratios, and Pc/S bilirubin ratios were examined in pericardial effusions. The results were not as reliable as those found using the preceding two methods. The results of these biochemical tests are summarized in Table 2 .
In this study population, only 6 of 110 pericardial effusions originated from transudative causes. While this may suggest that the majority of large, clinically significant pericardial effusions are due to exudative causes, it must be emphasized that the incidence of the various types of pericardial effusions seen in this study population differs significantly from first-world countries. Tuberculosis, which accounts for Ͻ 4% of all cases in first-world countries, 20 was the most prevalent cause in this series, where it accounted for approximately 58% of all pericardial effusions.
Laboratory tests are a useful guideline when assessing the etiology of pericardial effusions. The initial distinction between transudates and exudates gives an indication of the pathophysiologic mechanisms, the differential diagnoses, and the need for further investigations. It is important, however, that when making this distinction, these tests are interpreted in conjunction with the physician's clinical acumen. 
